<The> validation study of adjuvant online using Iranian breast cancer data

K., Mojir Sheibani; K., Novin; M., Tabatabaeefar; P.R., Azadeh; A., Mafi; S., Moghadam; F., Hoseini Kamal; A., Ghanbari Motlagh

validation study of adjuvant online using Iranian breast cancer data

K., Mojir Sheibani; K., Novin; M., Tabatabaeefar; P.R., Azadeh; A., Mafi; S., Moghadam; F., Hoseini Kamal; A., Ghanbari Motlagh.

Reports of Radiotherapy and Oncology. 2013; 1 (3): 97-102

in English | IMEMR | ID: emr-173627

ABSTRACT

ABSTRACT

Introduction:

Adjuvant Online! [AOL] is used extensively by oncologists in Iran to treat patients with breast cancer; however, it has never been validated for use in Iran, and its predictions might not be applicable to Iranian patients. The aim of this study was to evaluate the usefulness of this program in predicting the outcomes of Iranian patients with breast cancer

Search on Google

XML

Index: IMEMR (Eastern Mediterranean) Language: English Journal: Rep. Radiother. Oncol. Year: 2013

Similar

MEDLINE

LILACS

LIS

Search on Google

XML

Index: IMEMR (Eastern Mediterranean) Language: English Journal: Rep. Radiother. Oncol. Year: 2013